SEASONALFLU.INFO

LEIDEN, NETHERLANDS–(Marketwire – 02/09/10) – Crucell Announces Record Revenues and Profits for Full Year 2009 Total revenues and other operating income increased 26% to EUR358.0 million. Operating profit increased more than four-fold to EUR39.0 million. Net profit increased 68% to EUR23.9 million. Undiluted EPS increased 55% to EUR0.34. Year-end cash and short-term liquidities EUR428.0 million …

Go here to see the original:
Crucell Announces Record Revenues and Profits for Full Year 2009 (Marketwire via Yahoo! Finance)

AMSTERDAM – U.S. health care products maker Johnson & Johnson Inc. has bought an 18 percent stake in Dutch biotechnology company Crucell NV for euro301.8 million ($440 million) in hopes of developing a universal flu vaccine, the companies said Monday.

Link:
J&J buys 18 pct stake in Crucell for $440M, plans to cooperate in developing new flu treatment (Minneapolis-St. Paul Star Tribune)